Structure of Crumbs tail in complex with the PALS1 PDZ–SH3–GK tandem reveals a highly specific assembly mechanism for the apical Crumbs complex
2014.11.10Li, Y., Wei, Z., Yan, Y., Wan, Q., Du, Q., & Zhang, M. (2014). Proceedings of the National Academy of Sciences, 111(49), 17444-17449.
The Crumbs (Crb) complex, formed by Crb, PALS1, and PATJ, is evolutionarily conserved in metazoans and acts as a master cellgrowth and -polarity regulator at the apical membranes in polarized epithelia. Crb intracellular functions, including its direct binding to PALS1, are mediated by Crb’s highly conserved 37-residue cytoplasmic tail. However, the mechanistic basis governing the highly specific Crb– PALS1 complex formation is unclear, as reported interaction between the Crb tail (Crb-CT) and PALS1 PSD-95/DLG/ZO-1 (PDZ) domain is weak and promiscuous. Here we have discovered that the PDZ–Src homolgy 3 (SH3)–Guanylate kinase (GK) tandem of PALS1 binds to Crb-CT with a dissociation constant of 70 nM, which is 100-fold stronger than the PALS1 PDZ–Crb-CT interaction. The crystal structure of the PALS1 PDZ–SH3–GK–Crb-CT complex reveals that PDZ–SH3–GK forms a structural supramodule with all three domains contributing to the tight binding to Crb. Mutations disrupting the tertiary interactions of the PDZ–SH3–GK supramodule weaken the PALS1–Crb interaction and compromise PALS1-mediated polarity establishment in Madin– Darby canine kidney (MDCK) cysts. We further show that specific target binding of other members of membrane-associated guanylate kinases (MAGUKs) (e.g., CASK binding to neurexin) also requires the presence of their PDZ–SH3–GK tandems.
- Recommend
-
2024-06-15
AIDA-1/ANKS1B Binds to the SynGAP Family RasGAPs with High Affinity and Specificity.
-
Demixing is a default process for biological condensates formed via phase separation
-
Short-distance vesicle transport via phase separation.
-
Phosphorylation-dependent membraneless organelle fusion and fission illustrated by postsynaptic density assemblies.
-
2023-10-03
Ca2+-induced release of IQSEC2/BRAG1 autoinhibition under physiological and pathological conditions